1406 / 1542
Clinical indications and outcomes
•
Gynaecological cancer
•
Used for cervix, endometrial, vaginal and vulva
cancers
•
Move from 2D to 3/4 D IGBT
•
Prostate cancer
•
As both monotherapy and boost with EBRT
•
Breast cancer
•
Accelerated Partial Breast Irradiation (APBI) and
boost
•
Head and neck cancers
•
As primary treatment and salvage after previous
EBRT